Aldeyra Therapeutics, Inc. 10-Q filing
Filed 2025-11-05 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-266989
- Form type
- 10-Q
- CIK
- 0001341235
- Primary document
- https://www.sec.gov/Archives/edgar/data/1341235/000119312525266989/aldx-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aldeyra Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-28.6M | - | - |
| Net Income | $-27.4M | - | - |
| Eps Basic | -0.46 | - | - |
| Eps Diluted | -0.46 | - | - |
| Cash And Equivalents | $59.3M | - | - |
| Total Assets | $77.8M | - | - |
| Total Liabilities | $28.6M | - | - |
| Shareholders Equity | $49.2M | - | - |
| Operating Cash Flow | $-28.0M | - | - |